HCA stock: buy or sell?
February 21st, 2020
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States and England. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Should I buy HCA stock?Trading stocks requires experience and discipline, and your buying and selling decisions must come following a methodology. That's why is so important to choose your own trading strategy that fits your character as inversor. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.
None of our preferred buy setups matches with HCA Healthcare stock situation right now, hence this is not a suitable entry point.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is HCA Healthcare stock a buy?
Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness.Unfortunately, we couldn't find any rating for HCA stock for the last month.
HCA stock analysis
HCA Healthcare remained stable -0.07% to $148.00 after marking all time highs on Feb/13.
HCA Healthcare remained stable -0.07% to $148.00 after topping to all time highs on February 13th. Since SMA100d and SMA200d crossed up on December, HCA price slid a -0.51%. Since price and SMA200d lines crossed up on October, HCA climbed $21.49 (16.99%). HCA is soaring again after a 3.40% correction from its last top on February/13 at $151.97. On February 13th, HCA hit a new all time high, pushing higher than on Feb/6 tops. Check different trading setups that use ATHs as triggers.
HCA Healthcare decreased a bad -1.05% this week.
Not so far away is the last all-time high HCA Healthcare marked last week. Since price and SMA40w lines crossed up late October 2019, HCA climbed $22.09 (17.54%).
HCA stock price history
HCA IPO was on March 10th, 2011 at $24.41 per share1. Since then, HCA stock surged a 506.30%, with an average of 63.30% per year. If you had invested $1,000 in HCA stock in 2011, it would worth $5,063.00 today.
1: Adjusted price after possible price splits or reverse-splits.
HCA stock historical price chart
HCA stock reached all-time highs on February 13th with a price of $151.97.
HCA stock price targetPredicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. For the last month we have not found any price prediction for HCA Healthcare stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per ShareAfter publishing its last earnings report on April, HCA Healthcare . Unfortunately, reported EPS is not yet available in our database.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn 2018, HCA Healthcare annual turnover rose a great 7.02% to $46,677.00 million USD from $43,614.00 marked in 2017. Likewise, its income margin (compared to sales) appreciated to 8.11%, that is $3,787.00 million. HCA Healthcare fiscal year ends in December, and to compare its evolution since then, we estimate annual sales and income figures by adding results from the last 4 quarters. This is called TTM (or Twelve Trailing Months). So, HCA Healthcare TTM sales up to March 2019 were $47,771.00 and income $3,682.00 million USD. When comparing this TTM figures with the last reported annuality, we can esteem HCA Healthcare business evolution since December 2018: Annual revenues up to March, compared to lastest yearly report, raised a slightly good 2.34%. However, profit margin (net income/revenues) remained constant at 8.11%.
|2013||$34,180 M||-||$1,560 M4.6%||-|
|2014||$36,918 M||8.01%||$1,875 M5.1%||20.19%|
|2015||$39,678 M||7.48%||$2,129 M5.4%||13.55%|
|2016||$41,490 M||4.57%||$2,890 M7.0%||35.74%|
|2017||$43,614 M||5.12%||$2,216 M5.1%||-23.32%|
|2018||$46,677 M||7.02%||$3,787 M8.1%||70.89%|
|TTM||$47,771 M||2.34%||$3,682 M7.7%||-2.77%|
Quarterly financial resultsHCA Healthcare reported $12,517.00 M in revenues for 2019-Q1, a 1.98% improvement compared to previous quarter. Reported quarter income marked $1,039.00 M with a profit margin of 8.30%. Profit margin remained steady a -0.37% compared to previous quarter when profit margin was 8.67%. When comparing sales to same quarter last year, HCA Healthcare sales marked a wonderful increase and jumped a 9.58%. Looking back to recent quarterly results, HCA Healthcare posted 2 negative quarters in a row.
|2017-Q2||$10,730 M||-||$657 M6.1%||-|
|2017-Q3||$10,700 M||-0.28%||$426 M4.0%||-35.16%|
|2017-Q4||$11,562 M||8.06%||$474 M4.1%||11.27%|
|2018-Q1||$11,423 M||-1.20%||$1,144 M10.0%||141.35%|
|2018-Q2||$11,529 M||0.93%||$820 M7.1%||-28.32%|
|2018-Q3||$11,451 M||-0.68%||$759 M6.6%||-7.44%|
|2018-Q4||$12,274 M||7.19%||$1,064 M8.7%||40.18%|
|2019-Q1||$12,517 M||1.98%||$1,039 M8.3%||-2.35%|
HCA Healthcare ownershipWhen you are planning to invest in a stock, it's always worth to review its ownership structure.
HCA Healthcare shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 21.57% of all shares.
In case of HCA Healthcare stock, 72.20% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for HCA stock account 0.00%, no big difference from last month.
For a better context understanding, the next table shows ownership data compared to other related stocks:
|Market cap||$50.2 B|
|Total shares||339.2 M|
|Float shares||264.2 M|
|- Institutional holdings (%)||72.2%|
|- Insider holdings (%)||21.6%|
|Shares in short selling||0.0%|
|Friday, February 21st, 2020|
|Day range||$146.80 - $149.15|
|Average true range||$3.20|
|50d mov avg||$146.68|
|100d mov avg||$138.48|
|200d mov avg||$133.05|
HCA Healthcare performancePerformance as an absolute value is never valid if it's not benchmarked against competitors or related stocks in the industry. We chose as the bechmarking frame for HCA Healthcare stock.
HCA Healthcare competitorsUnfortunately, we could not find any public company that could be defined as HCA Healthcare competitor. This doesn't mean HCA Healthcare does not have any competitor in the market, it's just we could not detected it.
Latest HCA stock news
- Seeking AlphaKeep Your Portfolio Healthy With HCA HealthcareJune 4, 2019
- Seeking AlphaFinancial Exchange Stock Talk: Ranjit Thomas On HCA HealthcareDecember 19, 2018